+44 (0) 2082046722

References

NCI (2014, August 4) Molecular mechanism identified for activation and desensitisation of prominent neurotransmitter receptor in the brain. Retrieved from https://www.cancer.gov/news-events-/press-releases/2014/glutamatereceptors

Zarate, C Ionescu, D Niciu M (2013, December 8) Glutamate and its receptors in the pathophysiology and treatment of the major depressive disorder. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4048804/#dm139944332535696title

Johnson, C (2019, April 20) A Esketamine revolution for depression and pain? Spravato, fibromyalgia and ME/CFS. Retrieved from https://www.healthrising.org/blog/2019/04/20/Esketamine -fibromyalgia-spravato-esEsketamine -chronic-fatigue/

Popiolek K, Bejerot S, Brus O, Hammar A, Landen M, Lundberg J, Nordanskog P, Nordenskjoid (2019, July 23) Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors. Retrieved from https://onlinelibray.wiley.com/doi/full/10.1111/acps.13075

Tracy N, (2014, November 30) Bipolar Depression Treatment – – What to do if ECT Fails. Retrieved from https://www.healthyplace.com/blogs/breakingbipolar/2014/11/bipolar-depression-treatment-what-to-do-if-ect-fails

Purse M, (2020, March 22) How ECT is used for treating depression. Retrieved from https://www.verywellmind.com/ect-for-depression-and-anxiety-379903